AXGN
Axogen, Inc.
Latest Form 4:Sale$647KbyWendell Amy McBride (Director) · filed Aug 12, 2026
Axogen, Inc. (AXGN) has 47 SEC Form 4 filings (106 transaction rows) in the rolling window, disclosed by 12 distinct insiders. Most recent filing: Aug 12, 2026.
The most active filer is Director Burke William P. Mr. with 10 filings. Insiders have net sold $6.3M over the trailing 6 months.
- Industry:Medical - Devices
- CEO:Michael D. Dale
- Employees:451
- HQ:Alachua, FL, US
- IPO:1986-12-17
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$19.7M
reported sales (SEC code S)
Unique Insiders
12
in the rolling window
Market Cap
$2.8B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Wendell Amy McBrideFirst in 3 months | Director | Sale | 13,353 | $647K | Aug 12 | SEC ↗ |
Began Marc AFirst in 8 months | EVP & General Counsel | Sale | 67,500 | $3.2M | Aug 12 | SEC ↗ |
Weiler Kathy JohnsonFirst in 3 months | Director | Sale | 14,150 | $641K | Aug 11 | SEC ↗ |
| Director | Sale | 1,647 | $70K | May 12 | SEC ↗ | |
Hartley Lindsey MarieFirst in 5 months | CFO | Sale | 1,051 | $46K | May 8 | SEC ↗ |
Weiler Kathy JohnsonFirst in 5 months | Director | Sale | 16,344 | $721K | May 8 | SEC ↗ |
JOHNSON JOHNFirst in 5 months | Director | Sale | 11,050 | $478K | May 8 | SEC ↗ |
Kemp JensFirst in 5 months | Chief Marketing Officer | Sale | 4,000 | $174K | May 8 | SEC ↗ |
Quackenbush DorisFirst filing | Sales VP | Sale | 3,878 | $169K | May 8 | SEC ↗ |
DeVinney Erick WayneFirst in 3 months | Chief Innovation Officer | Sale | 5,221 | $171K | Mar 18 | SEC ↗ |
Weiler Kathy JohnsonFirst filing | Director | Sale | 46,653 | $1.4M | Dec 17 | SEC ↗ |
Wendell Amy McBrideFirst filing | Director | Sale | 43,684 | $1.3M | Dec 17 | SEC ↗ |
| CFO | Sale | 14,812 | $442K | Dec 17 | SEC ↗ | |
| Chief Executive Officer | Sale | 25,000 | $750K | Dec 12 | SEC ↗ | |
| EVP & General Counsel | Sale | 13,222 | $397K | Dec 12 | SEC ↗ | |
JOHNSON JOHNFirst filing | Director | Sale | 23,693 | $740K | Dec 10 | SEC ↗ |
JOHNSON JOHNFirst filing | Director | Sale | 21,686 | $650K | Dec 10 | SEC ↗ |
Hartley Lindsey MarieFirst filing | CFO | Sale | 14,387 | $454K | Dec 10 | SEC ↗ |
TYNDALL JOSEPH A.First filing | Director | Sale | 25,108 | $778K | Dec 10 | SEC ↗ |
DALE MICHAEL DFirst filing | Chief Executive Officer | Sale | 61,463 | $1.9M | Dec 10 | SEC ↗ |
Kemp JensFirst filing | Chief Marketing Officer | Sale | 8,156 | $255K | Dec 10 | SEC ↗ |
| Chief Innovation Officer | Sale | 19,517 | $609K | Dec 10 | SEC ↗ | |
Began Marc AFirst filing | EVP & General Counsel | Sale | 9,278 | $290K | Dec 10 | SEC ↗ |
THOMAS PAULFirst filing | Director | Sale | 21,399 | $634K | Dec 10 | SEC ↗ |
| Director | Sale | 19,227 | $462K | Nov 13 | SEC ↗ | |
| Director | Sale | 3,591 | $86K | Nov 13 | SEC ↗ | |
| Director | Sale | 11,431 | $275K | Nov 7 | SEC ↗ | |
| Director | Sale | 5,347 | $128K | Nov 7 | SEC ↗ | |
| Director | Sale | 40,235 | $827K | Oct 31 | SEC ↗ | |
| Director | Sale | 18,248 | $420K | Oct 31 | SEC ↗ | |
| Director | Sale | 1,457 | $26K | Oct 24 | SEC ↗ | |
| Director | Sale | 736 | $13K | Oct 7 | SEC ↗ | |
Burke William P. Mr.First filing | Director | Sale | 10,020 | $180K | Oct 6 | SEC ↗ |
Burke William P. Mr.First filing | Director | Sale | 22,171 | $404K | Oct 6 | SEC ↗ |
DeVinney Erick WayneFirst filing | Chief Innovation Officer | Sale | 1,137 | $19K | Sep 16 | SEC ↗ |
Related companies
Axogen, Inc. is in the Healthcare sector.